Skip to content

Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients

Use of a Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03779984
Enrollment
112
Registered
2018-12-19
Start date
2019-05-31
Completion date
2024-02-01
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation;Difficult

Brief summary

This study was designed to compare the effectiveness of using a red-rubber catheter versus standard, direct insertion of a thermosoftened, lubricated nasal endotracheal tube into the naris to facilitate nasotracheal intubation in adults. This study will assess if the red-rubber catheter method leads to lower incidence and severity of epistaxis, faster time to intubation, and higher patient satisfaction compared to the current standard of care.

Detailed description

The study population for this prospective randomized controlled trial will consist of male and female adult subjects over the age of 18 having surgery requiring nasal tracheal intubation (NTI). Subjects will be randomized to either the Red Rubber Catheter (RRC) group or control group. Oxymetazoline nasal spray will be administered with 1 spray per nostril preoperatively. Premedication with glycopyrrolate 0.2 mg and benzodiazepine at discretion of provider will be given preoperatively. Subjects will then be brought into the operating room and placed on all standard ASA monitors (BP cuff, EKG, pulse oximetry). One spray of oxymetazoline per nostril will again be administered. Standard preoxygenation will be used with a face mask and 100% O2. After induction of anesthesia, provider will confirm mask ventilation and 1 more spray of oxymetazoline will be administered per nostril. Intubation will first be attempted via a naris. Size 6.5 nasotracheal RAE tubes (Shiley Nasal RAE Tracheal Tube with TaperGuard Cuff, manufactured by Coviden llc, Mansfield, MA 02048) will be used in female patients and size 7.5 in males. The tubes will be thermosoftened by allowing them to sit in warm saline prior to use. Water-based lubrication will be used for dilation and intubation. Time from insertion of RRC or NETT into nasal passage to first recording of end-tidal CO2 will be recorded. Direct video laryngoscopy will be used to facilitate placement of the nasotracheal RAE tube. Five minutes after intubation, a non-collaborating anesthesia provider blinded to the method of intubation will grade the severity of bleeding by performing direct video laryngoscopy, inspecting the posterior pharynx and using a scale - 1. No epistaxis (no blood observed on either the surface of the tube or the posterior pharyngeal wall); 2. Mild epistaxis (blood apparent on the surface of the tube or posterior pharyngeal wall); 3. Moderate epistaxis (pooling of blood on the posterior pharyngeal wall); 4. Severe epistaxis (a large amount of blood in the pharynx impeding nasotracheal intubation-before the epistaxis assessor enters the operating room, requiring suction for intubation or necessitating urgent orotracheal intubation.) Degree of patient satisfaction and nasal pain on the side of intubation will be rated on a numerical rating scale at 30 and 60 minutes in the post-anesthesia care unit.

Interventions

DEVICERed Rubber Catheter

Experimental group will be intubated with red rubber catheter guidance

DEVICEStandard nasal tracheal Intubation

Control group will be intubated with standard nasal tracheal tube without guidance

Sponsors

M.D. Anderson Cancer Center
CollaboratorOTHER
University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Outcome accessor and participants are blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18, male and female * Subjects undergoing surgery requiring NTI * ASA 1-3

Exclusion criteria

* History of anticoagulant use or coagulopathy * History of latex allergy * History of difficult airway * Anticipated difficult airway requiring awake intubation * Abnormal anatomy of the nasal passage (due to prior trauma, surgery, congenital defects, etc.) or basilar skull fracture * Patients unable to be placed in the sniffing position * Morbid obesity with BMI \> 40 * Pregnancy * ASA 4

Design outcomes

Primary

MeasureTime frameDescription
The Number of Participants With Nasal BleedingWithin 5 minutes following the nasal tracheal intubationThe number of participants with nasal bleeding within 5 minutes following nasal tube placement.

Secondary

MeasureTime frameDescription
The Number of Participants With Severe EpistaxisWithin 5 minutes following nasal intubationThe number of participants with severe epistaxis within 5 minutes following nasal tube placement.

Countries

United States

Participant flow

Participants by arm

ArmCount
Red Rubber Catheter Group
Red Rubber Catheter (RRC) guided nasal tracheal intubation; a RRC securely attached to nasal tracheal tube and the rounded end of the catheter introduced into a naris. Red Rubber Catheter: Experimental group will be intubated with red rubber catheter guidance
56
Standard Nasal Tracheal Intubation
The nasotracheal tube will be inserted into the nasal passage. Standard nasal tracheal Intubation: Control group will be intubated with standard nasal tracheal tube without guidance
56
Total112

Baseline characteristics

CharacteristicRed Rubber Catheter GroupStandard Nasal Tracheal IntubationTotal
Age, Continuous57.37 years
STANDARD_DEVIATION 16.5
56.75 years
STANDARD_DEVIATION 16.26
57.06 years
STANDARD_DEVIATION 16.31
Body Mass Index (BMI)27.28 Kg/m2
STANDARD_DEVIATION 5.01
26.33 Kg/m2
STANDARD_DEVIATION 4.9
26.81 Kg/m2
STANDARD_DEVIATION 4.95
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
56 participants56 participants112 participants
Sex: Female, Male
Female
21 Participants22 Participants43 Participants
Sex: Female, Male
Male
35 Participants34 Participants69 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 560 / 56
other
Total, other adverse events
0 / 560 / 56
serious
Total, serious adverse events
0 / 560 / 56

Outcome results

Primary

The Number of Participants With Nasal Bleeding

The number of participants with nasal bleeding within 5 minutes following nasal tube placement.

Time frame: Within 5 minutes following the nasal tracheal intubation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Red Rubber Catheter GroupThe Number of Participants With Nasal Bleeding22 Participants
Standard Nasal Tracheal IntubationThe Number of Participants With Nasal Bleeding35 Participants
Secondary

The Number of Participants With Severe Epistaxis

The number of participants with severe epistaxis within 5 minutes following nasal tube placement.

Time frame: Within 5 minutes following nasal intubation

Population: The number of patients with severe epistaxis in the use of the red rubber catheter vs. the standard insertion catheter

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Red Rubber Catheter GroupThe Number of Participants With Severe Epistaxis1 Participants
Standard Nasal Tracheal IntubationThe Number of Participants With Severe Epistaxis1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026